Liaoning Chengda Biotechnology Co's quarterly market cap
declined
from Sep. 2025 (¥11,203 Mil) to Dec. 2025 (¥10,728 Mil) and
declined
from Dec. 2025 (¥10,728 Mil) to Mar. 2026 (¥10,253 Mil).
Liaoning Chengda Biotechnology Co's annual market cap
declined
from Dec. 2023 (¥13,539 Mil) to Dec. 2024 (¥10,736 Mil) and
declined
from Dec. 2024 (¥10,736 Mil) to Dec. 2025 (¥10,728 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Liaoning Chengda Biotechnology Co's Enterprise Value for Today is ¥3,385 Mil.
Liaoning Chengda Biotechnology Co (SHSE:688739) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Liaoning Chengda Biotechnology Co Market Cap Related Terms
Liaoning Chengda Biotechnology Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Liaoning Chengda Biotechnology Co Market Cap Chart
SHSE:688739 vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, Liaoning Chengda Biotechnology Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Liaoning Chengda Biotechnology Co Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Liaoning Chengda Biotechnology Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Liaoning Chengda Biotechnology Co's Market Cap falls into.
Liaoning Chengda Biotechnology Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Liaoning Chengda Biotechnology Co (SHSE:688739) has a Market Cap of ¥8,183 Mil as of Jul. 07, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Liaoning Chengda Biotechnology Co and its competitors. According to the industry distribution chart, Liaoning Chengda Biotechnology Co ranks #259 out of 1421 companies in the Biotechnology industry, placing it in the top 18.2%.
Is Liaoning Chengda Biotechnology Co's Market Cap too high?
Liaoning Chengda Biotechnology Co's current Market Cap is ¥8,183 Mil. Based on the distribution chart, Liaoning Chengda Biotechnology Co ranks #259 out of 1421 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Liaoning Chengda Biotechnology Co has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Liaoning Chengda Biotechnology Co's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Liaoning Chengda Biotechnology Co ranks #259 out of 1421 companies for Market Cap. This places Liaoning Chengda Biotechnology Co in the top 18% of its industry — outperforming the majority of peers. The industry median Market Cap is 121.57. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 121.57, based on 1,421 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Liaoning Chengda Biotechnology Co and its competitors. For the Biotechnology industry, the median Market Cap is 121.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Liaoning Chengda Biotechnology Co's current Market Cap is ¥8,183 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Liaoning Chengda Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Liaoning Chengda Biotechnology Co (SHSE:688739) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥22.14, compared to a current price of ¥19.65 — trading 11.2% below its estimated fair value. The current Market Cap is ¥8,183 Mil. Liaoning Chengda Biotechnology Co's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Liaoning Chengda Biotechnology Co (SHSE:688739), the current Market Cap is ¥8,183 Mil as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Liaoning Chengda Biotechnology Co (SHSE:688739) Overvalued in 2026?
Based on GuruFocus' analysis, Liaoning Chengda Biotechnology Co stock appears to be undervalued.
The current stock price of ¥19.65 is trading 11.2% below its estimated GF Value™ of ¥22.14.
GuruFocus considers Liaoning Chengda Biotechnology Co to be Modestly Undervalued.
Key valuation signals for SHSE:688739:
Market Cap: ¥8,183 Mil
GF Value™: ¥22.14 vs. price of ¥19.65 (11.2% below fair value)
No single metric tells the full story. See the SHSE:688739 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Liaoning Chengda Biotechnology Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688739 has been successfully added to your 
